22 related articles for article (PubMed ID: 37789677)
1. Tumefactive Primary Central Nervous System Vasculitis: Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging Findings With Histological Correlation.
Muccio CF; Di Lorenzo L; Lepore G; Savarese F; Schipani S; Chiarotti I; Cerase A
Clin Ter; 2024; 175(2):112-117. PubMed ID: 38571468
[TBL] [Abstract][Full Text] [Related]
2. Low rCBV values in glioblastoma tumor progression under chemoradiotherapy.
Hilario A; Salvador E; Cardenas A; Romero J; Lechuga C; Chen Z; Martinez de Aragon A; Perez-Nuñez A; Hernandez-Lain A; Sepulveda J; Lagares A; Toldos O; Rodriguez-Gonzalez V; Ramos A
Neuroradiology; 2024 Mar; 66(3):317-323. PubMed ID: 38183424
[TBL] [Abstract][Full Text] [Related]
3. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.
Cho NS; Hagiwara A; Sanvito F; Ellingson BM
Neuroradiology; 2023 Mar; 65(3):559-568. PubMed ID: 36301349
[TBL] [Abstract][Full Text] [Related]
4. How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methods.
Herings SDA; van den Elshout R; de Wit R; Mannil M; Ravesloot C; Scheenen TWJ; Arens A; van der Kolk A; Meijer FJA; Henssen DJHA
Neuroradiology; 2024 May; ():. PubMed ID: 38714545
[TBL] [Abstract][Full Text] [Related]
5. Observer variability of reference tissue selection for relativecerebral blood volume measurements in glioma patients.
Oei MTH; Meijer FJA; Mordang JJ; Smit EJ; Idema AJS; Goraj BM; Laue HOA; Prokop M; Manniesing R
Eur Radiol; 2018 Sep; 28(9):3902-3911. PubMed ID: 29572637
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of volume analysis of dynamic susceptibility contrast perfusion-weighted imaging in untreated glioblastomas.
Roques M; Raveneau M; Adam G; De Barros A; Catalaa I; Patsoura S; Cognard C; Darcourt J; Bonneville F
Neuroradiology; 2022 Sep; 64(9):1763-1771. PubMed ID: 35364709
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
Saini J; Gupta RK; Kumar M; Singh A; Saha I; Santosh V; Beniwal M; Kandavel T; Cauteren MV
PLoS One; 2019; 14(4):e0215400. PubMed ID: 31017934
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.
Yüzkan S; Mutlu S; Karagülle M; Şam Özdemir M; Özgül H; Arıkan MA; Koçak B
Diagn Interv Radiol; 2024 Mar; 30(2):124-134. PubMed ID: 37789677
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
12. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
